NAD+ is a coenzyme your cells use for energy metabolism, cellular signaling, and DNA repair pathways. NMN is a precursor, meaning the body can convert it into NAD+.

For someone comparing oral supplements, NMN has stronger human evidence for raising blood NAD+ levels. Direct NAD+, especially NAD+ IV therapy, has far less evidence for lasting health benefits and requires more time, money, and medical supervision.

Key Takeaways:

• NAD+ supports energy metabolism and enzymes involved in DNA repair and cellular stress responses.

• NMN is converted into NAD+ through the body’s NAD salvage pathway.

• Human studies suggest that oral NMN can raise blood NAD+ levels, but proven health benefits remain limited.

• Direct NAD+ IV therapy has limited clinical evidence and may cause unpleasant infusion reactions.

What is NAD+?

NAD+, short for nicotinamide adenine dinucleotide, is a coenzyme found in living cells. It helps transfer electrons during metabolic reactions, allowing cells to turn carbohydrates, fats, and proteins into usable energy.

NAD exists in two closely connected forms:

• NAD+ is the oxidized form that accepts electrons.

• NADH is the reduced form that carries those electrons into other energy-producing reactions.

When supplement companies talk about “raising NAD,” they are generally referring to the NAD+ pool and related metabolites, not just NADH.

NAD+ also acts as a substrate for several groups of enzymes:

• Sirtuins, which help regulate metabolism and cellular stress responses

• PARPs, which participate in DNA damage signaling and repair

• CD38, an enzyme involved in immune signaling and NAD+ breakdown

Research in human tissue has found an association between older age, greater oxidative damage, and lower NAD+ availability. However, NAD+ decline does not happen at one fixed rate across every organ or every person (1).

This means claims such as “everyone loses 50% of their NAD+ between ages 40 and 60” are too broad. NAD+ measurements vary by tissue, testing method, health status, and age.

What is NMN?

NMN, or nicotinamide mononucleotide, is a naturally occurring nucleotide involved in NAD+ production.

The body can make NMN from nicotinamide, a form of vitamin B3. An enzyme called nicotinamide phosphoribosyltransferase, or NAMPT, helps create NMN. Another group of enzymes called NMN adenylyltransferases, or NMNATs, then converts NMN into NAD+.

In simple terms: Nicotinamide → NAMPT → NMN → NMNAT → NAD+

This recycling process is known as the NAD salvage pathway. It allows cells to reuse nicotinamide released when NAD+-consuming enzymes perform their jobs.

NMN is found in small amounts in foods such as broccoli, cabbage, cucumber, avocado, tomatoes, and edamame. Food amounts are far lower than the doses used in clinical trials, so eating these foods is not equal to taking a concentrated NMN supplement.

NAD+ vs NMN at a glance

A common problem with “NAD supplement” labels

A product marketed as an “NAD supplement” may not contain direct NAD+.

It may contain:

• NMN

• Nicotinamide riboside, or NR

• Niacin

• Nicotinamide

• NADH

• A mixture of several NAD+ precursors

These ingredients are related, but they are not interchangeable. Check the Supplement Facts panel instead of relying on the product name or front label.

“NAD support” is a marketing category, not the name of one specific ingredient.

How does NMN turn into NAD+?

After NMN reaches tissues, NMNAT enzymes add an adenosine-containing group to NMN, forming NAD+.

The final conversion is short, but NMN absorption and metabolism are more complicated than many product pages suggest. Researchers are still studying:

• How much intact NMN enters the bloodstream

• How much is first changed into nicotinamide riboside or nicotinamide

• How gut bacteria affect NMN metabolism

• Why blood NAD+ responses vary so much between people

• How blood NAD+ changes relate to NAD+ inside muscles, the brain, or other tissues

A rise in blood NAD+ confirms that the supplement affected the NAD system. It does not prove that every organ received the same increase or that the person gained a noticeable health benefit.

What do human studies say about NMN?

Human NMN research has grown, but most trials remain small and short. Many focus on blood NAD+ or other biomarkers rather than disease rates, lifespan, or long-term function.

NMN can raise blood NAD+ levels

A randomized trial gave 30 healthy adults either 250 mg of NMN or a placebo each day for 12 weeks. The NMN group had a significant increase in whole-blood NAD+ levels, with no clear safety problems found during the study period (2).

A larger trial included 80 adults aged 40 to 65. Participants received a placebo or 300 mg, 600 mg, or 900 mg of NMN daily for 60 days. Blood NAD+ rose in the NMN groups, and the supplement was reported as well tolerated during the short trial (3).

The response differed widely from one person to another. This matters because a dose that raises NAD+ strongly in one person may have a smaller effect in someone else.

Metabolic benefits are not settled

One widely discussed trial studied 25 postmenopausal women with prediabetes who were overweight or obese. Participants took 250 mg of NMN or a placebo daily for 10 weeks.

NMN improved muscle insulin sensitivity and some insulin-signaling measures. However, it did not produce broad improvements across every metabolic outcome measured (4).

This was an interesting finding in a specific population. It does not show that NMN improves blood sugar control in all adults.

A later systematic review examined 12 randomized trials with 513 participants. NMN increased blood NAD+ across the pooled research, but most glucose and cholesterol outcomes were not significantly different from placebo. The authors also found study-quality concerns across the included trials (5).

Physical function findings remain mixed

A small randomized trial studied 250 mg of NMN per day in older men. NMN raised blood NAD+ and related metabolites. Researchers also reported possible improvements in gait speed and one grip-strength measurement, but only 20 participants completed the full 12-week period (6).

Other small studies have reported signals related to walking, lower-limb function, fatigue, or sleep. Results differ between trials, and larger independent studies are needed before NMN can be recommended for physical performance.

NMN has not been proven to extend human lifespan

No completed human trial has shown that NMN:

• Extends lifespan

• Prevents aging

• Reverses biological age

• Prevents dementia

• Prevents heart disease

• Protects against cancer

• Replaces exercise, sleep, or a balanced diet

Animal findings can help researchers choose what to study next. They cannot confirm the same outcome in humans.

What does the research say about direct NAD+?

Direct NAD+ products come in oral, injectable, and intravenous forms. Each route needs to be considered separately.

Oral NAD+ supplements

There is little high-quality human research showing that standard oral NAD+ reliably raises intracellular NAD+ or produces clear health benefits.

NAD+ is a relatively large, charged molecule. It may be broken down into smaller compounds before being absorbed and reused.

Researchers continue to study extracellular NAD+ metabolism and possible transport routes, so it is more accurate to say that oral absorption is uncertain, not impossible.

Liposomal sprays, sublingual tablets, and other special delivery systems are promoted as solutions. Strong human comparisons showing that these forms outperform standard NMN capsules are lacking.

NAD+ IV therapy

NAD+ IV therapy sends NAD+ directly into the bloodstream. Clinics promote it for energy, mental clarity, recovery, addiction support, and healthy aging.

The clinical evidence does not support most of those claims.

A 2019 pilot study infused 750 mg of NAD+ over six hours. Researchers measured changes in blood and urine metabolites, showing that infused NAD+ was rapidly processed by the body. The study examined metabolism and short-term laboratory markers, not anti-aging effects or long-term health outcomes (7).

A 2026 retrospective pilot reviewed 14 people who received four consecutive days of either 500 mg NAD+ IV or 500 mg NR IV. The NAD+ IV group needed a longer average infusion time and reported more difficult reactions, including nausea, digestive distress, increased heart rate, and chest pressure.

The study had no placebo group, included very few participants, and was not designed to prove effectiveness (8).

NAD+ IV therapy may change circulating NAD-related metabolites, but current research does not show that it is better than oral NMN for energy, longevity, cognitive health, or disease prevention.

NAD+ vs NMN: Which one is better?

For someone choosing a daily oral product, NMN is the more research-supported option.

That does not mean NMN has been proven to slow aging. It means that:

• Oral NMN has been studied in several placebo-controlled human trials.

• Multiple trials found increases in blood NAD+.

• Daily use is more convenient than an IV infusion.

• Trial doses and short-term safety data are easier to evaluate.

• Direct oral NAD+ does not have the same level of supporting human research.

Direct NAD+ may make sense in a research or medically supervised setting. It should not be viewed as a proven upgrade from NMN.

Best option by goal

How much NMN should you take?

There is no official standard dose for NMN. Human trials have tested a wide range, including:

• 250 mg per day for 10 to 12 weeks

• 300 mg per day for 60 days

• 600 mg per day for 60 days

• 900 mg per day for 60 days

• Higher amounts in small pharmacokinetic studies

Many current products provide 250 to 500 mg per serving. This range is close to the dose used in several published human trials, but it should not be treated as a guaranteed effective dose.

A larger amount is not automatically better. Studies have not established the ideal dose for energy, healthy aging, physical performance, or long-term health.

One small 2026 pharmacokinetic study used 1,200 mg per day of NMN or NR in 12 participants. Blood NAD+ rose gradually, while measurable brain NAD+ changes appeared after several weeks. The study was designed to examine how NAD+ changes over time, not to prove clinical benefits (9).

How long does NMN take to work?

NMN may change blood NAD+ within days or weeks, but there is no proven timeline for feeling more energetic, sleeping better, or noticing another benefit.

Blood NAD+ changes and personal symptoms are not the same outcome.

Some people may report a subjective difference quickly. Others may feel nothing even when a laboratory marker changes. Current research does not support promises such as “more energy in seven days” or “reversed aging in three months.”

The 2026 pharmacokinetic study found that blood NAD+ increased gradually and reached a plateau after around two weeks of continued precursor use. Brain NAD+ changes took closer to four weeks (9).

NMN and NAD+ side effects

NMN side effects

Short-term NMN trials have reported good tolerability at doses from 250 to 900 mg per day. Serious supplement-related events were not a common finding in these studies (2,3).

Some users may experience:

• Nausea

• Bloating

• Loose stool

• Stomach discomfort

• Headache

These symptoms are not well documented across all NMN trials, and reactions may come from other ingredients in the formula rather than NMN itself.

Long-term safety remains unclear because most human studies have lasted only a few weeks or months.

NAD+ IV side effects

NAD+ infusions may cause more noticeable reactions, especially when administered quickly.

Reported reactions include:

• Nausea

• Vomiting

• Diarrhea

• Abdominal discomfort

• Increased heart rate

• Chest pressure

• Headache

• Flushing

• Cramping

In the 2026 pilot comparison, side effects forced clinicians to administer NAD+ more slowly than NR (8).

Any NAD+ infusion should take place under qualified medical supervision with appropriate screening and monitoring.

Who should speak with a healthcare professional first?

Medical guidance is especially important for people who:

• Are pregnant or breastfeeding

• Are under 18

• Take prescription medications

• Have diabetes or use glucose-lowering medicine

• Have kidney or liver disease

• Have a history of cancer

• Are receiving chemotherapy, radiation, or immunotherapy

• Are preparing for surgery

• Have an unexplained health symptom they hope a supplement will fix

Many NMN trials excluded people with significant medical conditions. A lack of reported harm in healthy research participants does not confirm safety for every group.

Is NMN legal in the United States?

Yes. The FDA’s current position allows NMN to fall within the US dietary supplement definition.

In 2022, the FDA took the position that NMN could not be marketed as a dietary supplement because it had been authorized for investigation as a drug.

On September 29, 2025, the agency changed its position. It concluded that NMN had been marketed as a dietary supplement before the relevant drug authorization and was not excluded from the dietary supplement definition (10).

This does not mean that the FDA has approved NMN for safety, effectiveness, healthy aging, or disease prevention. Dietary supplements do not go through the same premarket approval process as prescription drugs.

Can you take NMN and NAD+ together?

There is no good evidence that taking oral NMN and direct NAD+ together works better than taking NMN alone.

NMN already feeds into the NAD+ production pathway. Adding another NAD-related product may increase cost and complexity without delivering a measurable benefit.

The same point applies to combining several precursors such as NMN, NR, niacin, and nicotinamide. More ingredients do not automatically create a stronger formula.

Anyone considering oral NMN alongside NAD+ injections or IV therapy should discuss the combination with the supervising clinician.

Can you take NMN with resveratrol?

NMN and resveratrol are commonly paired because NAD+ supports sirtuin activity, while resveratrol has been studied for its possible effects on cellular stress pathways.

However, human research has not established that an NMN and resveratrol combination raises NAD+ more effectively or produces better healthy-aging outcomes than NMN alone.

The two ingredients may still fit into the same formula, but the pairing should be presented as a research-informed combination rather than a proven longevity stack.

How to choose an NMN supplement

Look beyond the front label and marketing claims.

A good NMN product should provide:

• Beta-NMN clearly listed on the label

• The exact amount per serving

• Third-party testing for identity and purity

• Screening for microbes and heavy metals

• A lot-specific certificate of analysis

• Clear manufacturing and storage information

• No hidden proprietary blend

Be cautious with claims that one delivery form is several times more absorbable than another. Strong independent human comparisons between capsules, powders, sublingual tablets, and liposomal NMN are limited.

Final words

NAD+ and NMN are connected, but they are not the same molecule. NAD+ carries out important work inside cells. NMN supplies material the body can convert into NAD+.

For oral supplementation, NMN has stronger human evidence than direct NAD+. Research shows that it can raise blood NAD+, but clear anti-aging, energy, metabolic, and longevity benefits have not been established.

That distinction matters. Raising a biomarker is promising. Proving that the change helps people live longer or healthier lives is a much bigger step.

Our Omre NMN + Resveratrol provides 500 mg of NMN alongside micronized trans-resveratrol in a clearly labeled formula.

Check out the product if you are looking for a simple, third-party-tested option built around doses used in human research.

FAQs

Is NMN the same as NAD+?

No. NMN is a precursor that the body can convert into NAD+. NAD+ is the coenzyme used directly in energy metabolism, redox reactions, and enzyme activity.

Does NMN raise NAD+ levels?

Several short-term human trials have found that oral NMN raises blood NAD+ or related metabolites. The size of the response can vary considerably between people (2,3).

Is NAD+ IV better than NMN?

There is no strong evidence showing that NAD+ IV produces better health outcomes than oral NMN. IV therapy places NAD+ directly into the bloodstream, but it is more expensive, less convenient, and may cause unpleasant infusion reactions.

What is the difference between NAD+ and NADH?

NAD+ accepts electrons during metabolic reactions and becomes NADH. NADH carries those electrons and helps support ATP production. They are two forms of the same coenzyme system.

Can NMN reverse aging?

No human research has shown that NMN reverses aging or extends lifespan. It can raise blood NAD+, but the long-term health meaning of that increase remains under study.

References

1. Massudi, H., Grant, R., Braidy, N., Guest, J., Farnsworth, B., & Guillemin, G. J. (2012). Age-associated changes in oxidative stress and NAD+ metabolism in human tissue. PLOS ONE, 7(7), e42357.

2. Okabe, K., Yaku, K., Uchida, Y., et al. (2022). Oral administration of nicotinamide mononucleotide is safe and efficiently increases blood nicotinamide adenine dinucleotide levels in healthy subjects. Frontiers in Nutrition, 9, 868640.

3. Yi, L., Maier, A. B., Tao, R., et al. (2023). The efficacy and safety of β-nicotinamide mononucleotide supplementation in healthy middle-aged adults. GeroScience, 45(1), 29–43.

4. Yoshino, M., Yoshino, J., Kayser, B. D., et al. (2021). Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women. Science, 372(6547), 1224–1229.

5. Zhang, J., Poon, E. T. C., & Wong, S. H. S. (2025). Efficacy of oral nicotinamide mononucleotide supplementation on glucose and lipid metabolism for adults. Critical Reviews in Food Science and Nutrition, 65(22), 4382–4400.

6. Igarashi, M., Nakagawa-Nagahama, Y., Miura, M., et al. (2022). Chronic nicotinamide mononucleotide supplementation elevates blood NAD+ levels and alters muscle function in healthy older men. npj Aging, 8, 5.

7. Grant, R., Berg, J., Mestayer, R., et al. (2019). A pilot study investigating changes in the human plasma and urine NAD+ metabolome during a 6-hour intravenous infusion of NAD+. Frontiers in Aging Neuroscience, 11, 257.

8. Reyna, K., Heinzen, G., Patel, N., et al. (2026). Intravenous infusion of nicotinamide adenine dinucleotide versus nicotinamide riboside: A retrospective tolerability pilot study in a real-world setting. Frontiers in Aging, 7, 1652582.

9. Berven, H., Svensen, M., Eikeland, H., et al. (2026). The NAD-brain pharmacokinetic study of NAD augmentation in blood and brain using oral precursor supplementation. iScience, 29(3), 114764.

10. U.S. Food and Drug Administration. (2025). Response to citizen petition regarding the dietary supplement status of beta-nicotinamide mononucleotide.